SCHEMBL4295922

SCHEMBL4295922

Cc1cc(-c2ccccc2Nc2nc3ccc(F)cc3s2)ccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
HPGD P15428 3/20 0.50
KMT2A Q03164 3/20 0.50
HTT P42858 3/20 0.50
KDM4E B2RXH2 3/20 0.50
LMNA P02545 3/20 0.50
MEN1 O00255 2/20 0.50
GAA P10253 2/20 0.50
TNF P01375 1/20 0.50
NR2F2 P24468 1/20 0.50
MCL1 Q07820 1/20 0.50
KLF5 Q13887 1/20 0.50
NOD1 Q9Y239 1/20 0.50
ALDH1A1 P00352 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
ALPL P05186 1/20 0.49
USP2 O75604 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1761329 0.86 DGAT1 (0.61) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL1761569 0.84 DGAT1 (0.62) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL27706428 0.79 LRRK2 (0.57) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL13249174 0.78 DGAT1 (0.59) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL4295916 0.78 MAPT (0.53) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL1761458 0.77 DGAT1 (0.63) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL4284382 0.77 MAPT (0.49) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL1761642 0.77 MAPT (0.61) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL1761741 0.74 DGAT1 (0.55) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL3127967 0.74 MAPT (0.63) MAPTSMN1; SMN2NPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805156-A4 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORP (US) 2009-06-10 EP disclosed
EP-1805156-A2 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY Bayer Pharmaceuticals Corporation (US) 2007-07-11 EP disclosed
WO-2006044775-A2 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORPORATION (US) 2006-04-27 WO disclosed